Evidence map›Paper›PMID 32894139›Full record

ArticleCell communication and signaling : CCS2020

Molecular basis of carrageenan-induced cytokines production in macrophages.

Alexandre H Lopes, Rangel L Silva, Miriam D Fonseca, Francisco I Gomes, Alexandre G Maganin, Lucas S Ribeiro, Lucas Maciel Mauriz Marques, Fernando Q Cunha, Jose C Alves-Filho, Dario S Zamboni and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 65 citations in OpenAlex.

  1. Carrageenan-induced immunothrombotic models in rodents (Review).Experimental and therapeutic medicine · 2026
    Review
  2. Curcumin analogues suppress cellular pro-inflammatory mediators and reduce edema.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Cannabigerol ExertsJournal of microbiology and biotechnology · 2025
    Article
  10. Article
  11. Article
  12. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Article
  15. The Potential Utility of (2S,4R)-4-[Molecular imaging and biology · 2025
    Article
  16. Review
  17. Cardioprotective effects ofFrontiers in pharmacology · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Alexandre H LopesDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Rangel L SilvaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Miriam D FonsecaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Francisco I GomesDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Alexandre G MaganinDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Lucas S RibeiroInstitute of Innate Immunity, University Hospitals, University of Bonn, 53127, Bonn, Germany.
Lucas Maciel Mauriz MarquesDepartment of Physics and Chemistry, University of São Paulo, Ribeirão Preto, SP, Brazil.
Fernando Q CunhaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Jose C Alves-FilhoDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Dario S ZamboniDepartment of Cellular and Molecular Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
Norberto P LopesDepartment of Physics and Chemistry, University of São Paulo, Ribeirão Preto, SP, Brazil.
Bernardo S FranklinInstitute of Innate Immunity, University Hospitals, University of Bonn, 53127, Bonn, Germany.
Aurélie GombaultUniversity of Orleans and CNRS, UMR7355 Experimental and Molecular Immunology, Orleans, France.
Fernando Silva RamalhoDepartment of Pathology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Valerie F J QuesniauxUniversity of Orleans and CNRS, UMR7355 Experimental and Molecular Immunology, Orleans, France.
Isabelle CouillinUniversity of Orleans and CNRS, UMR7355 Experimental and Molecular Immunology, Orleans, France.
Bernhard RyffelUniversity of Orleans and CNRS, UMR7355 Experimental and Molecular Immunology, Orleans, France.
Thiago M CunhaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil. thicunha@fmrp.usp.br.ORCID 0000-0002-7855-3700
Universidade de São Paulo · BRUniversité d'Orléans · FRUniversity of Bonn · DEUniversidade de Ribeirão Preto · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLow molecular weight carrageenan (Cg) is a seaweed-derived sulfated polysaccharide widely used as inflammatory stimulus in preclinical studies. However, the molecular mechanisms of Cg-induced inflammation are not fully elucidated. The present study aimed to investigate the molecular basis involved in Cg-induced macrophages activation and cytokines production.

methodsPrimary culture of mouse peritoneal macrophages were stimulated with Kappa Cg. The supernatant and cell lysate were used for ELISA, western blotting, immunofluorescence. Cg-induced mouse colitis was also developed.

resultsHere we show that Cg activates peritoneal macrophages to produce pro-inflammatory cytokines such as TNF and IL-1β. While Cg-induced TNF production/secretion depends on TLR4/MyD88 signaling, the production of pro-IL-1β relies on TLR4/TRIF/SYK/reactive oxygen species (ROS) signaling pathway. The maturation of pro-IL1β into IL-1β is dependent on canonical NLRP3 inflammasome activation via Pannexin-1/P2X7/K

conclusionsIn conclusion, we unravel a critical role of the NLRP3 inflammasome in Cg-induced pro-inflammatory cytokines production and colitis, which is an important discovery on the pro-inflammatory properties of this sulfated polysaccharide for pre-clinical studies. Video abstract Carrageenan (Cg) is one the most used flogistic stimulus in preclinical studies. Nevertheless, the molecular basis of Cg-induced inflammation is not totally elucidated. Herein, Lopes et al. unraveled the molecular basis for Cg-induced macrophages production of biological active IL-1β. The Cg-stimulated macrophages produces pro-IL-1β depends on TLR4/TRIF/Syk/ROS, whereas its processing into mature IL-1β is dependent on the canonical NLRP3 inflammasome.

Indexed as

Macrophage ActivationAnimalsCarrageenanCells, CulturedCytokinesInflammasomesInflammationInterleukin-1betaMacrophages, PeritonealMaleMiceMice, Inbred C57BLNLR Family, Pyrin Domain-Containing 3 ProteinTumor Necrosis Factor-alphaCarrageenanCytokinesIL1B protein, mouseInflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseTumor Necrosis Factor-alphaCarrageenanIL-1βMacrophagesNLRP3 InflammasomePannexin-1 channel

Identifiers

PMID32894139
PMCPMC7487827
OpenAlexW3083539026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.